 | | | | | | | | | | | | | |
 |
[
admission conditions
] [
] [
]
|
Advanced Master in Industrial Pharmacy
 |
Th
|
Pr
|
Au
| Credits
|
A single year
|
Compulsory courses
|
|
PHIN2004-1
|
Active substances
|
|
|
| 6
|
| |
- Substances issues de recherches pharmacochimiques, part a - Bernard Pirotte
| 10
| -
| -
| |
| |
- Substances issues de recherches pharmacochimiques, part b - Françoise Dufrasne
| 5
| -
| -
| |
| |
- Substances issues des biotechnologies - Jean‑Paul Dehaye
| 15
| -
| -
| |
| |
- Substances d'origine naturelle, part a - Joëlle Quetin‑Leclercq
| 5
| -
| -
| |
| |
- Substances d'origine naturelle, part b - Pierre Duez
| 5
| -
| -
| |
| |
- Produits radiopharmaceutiques - Ghanem Ghanem
| 10
| -
| -
| |
|
PHIN2008-2
|
Clinical viewpoints
|
|
|
| 6
|
| |
- Métabolisme des médicaments et paramètres pharmacocinétiques - Roger Verbeek
| 20
| -
| -
| |
| |
- Aspects théoriques et pratiques des études cliniques (y compris les méthodes statistiques appliquées aux études cliniques) - André Scheen
| 15
| -
| -
| |
| |
- Information et pharmacovigilance - Corinne Charlier
| 10
| -
| -
| |
|
PHIN2013-2
|
Quality assurance and pharmaceutical management
|
|
|
| 7
|
| |
- Principles of pharmaceutical management - Jean‑Michel Van Der Hofstadt
| 10
| -
| -
| |
| |
- Quality assurance, part a : basic concepts and quality assurance organisation - Jean Scouvart
| 20
| -
| -
| |
| |
- Quality assurance, part b : Analytical technology of procedures and risk analysis - Xavier Marcelis
| 7,5
| -
| -
| |
| |
- English applied to the pharmaceutical industry - Jennifer Moreman, Jacques Poupaert, Nevin Serbest
| 20
| -
| -
| |
| |
- Pharmaceutical marketing - Vincent Bierlaire
| 7,5
| -
| -
| |
|
PHIN2022-1
|
Industrial pharmaceutical technology
|
|
|
| 8
|
| |
- Microbiologie pharmaceutique industrielle - Véronique Fontaine
| 15
| -
| -
| |
| |
- Préformulation et sélection des formes galéniques - Karim Amighi
| 15
| -
| -
| |
| |
- Production industrielle des formes galéniques - Brigitte Evrard
| 15
| -
| -
| |
| |
- Génie pharmaceutique - Jean Gillard
| 15
| -
| -
| |
| |
- Aspects industriels du développement technologique y compris le conditionnement - Laurence Denis
| 10
| -
| -
| |
|
PHIN2023-1
|
Drug analysis
|
|
|
| 7
|
| |
- Analytical methods and pharmaceutical and biopharmaceutical control, part a - Jean‑Michel Kauffman
| 10
| -
| -
| |
| |
- Analytical methods and pharmaceutical and biopharmaceutical control, part b - Marianne Fillet
| 10
| -
| -
| |
| |
- Methods in pharmaceutical and biopharmaceutical analysis, part a : Validation and qualification of equipment - Philippe Hubert, Eric Rozet
| 15
| -
| -
| |
| |
- Methods in pharmaceutical and biopharmaceutical analysis, part b : Process analytical technology - Philippe Hubert, Eric Ziemons
| 5
| -
| -
| |
| |
- Statistical methods applied to the pharmaceutical industry - Bernadette Govaerts
| 15
| -
| -
| |
| |
- Experimental planning and "quality by design" - Bruno Boulanger
| 10
| -
| -
| |
|
PHIN2029-2
|
Regulation and the medical-social environment
|
|
|
| 8
|
| |
- Aspects économiques du développement du médicament - Dominique Martin
| 10
| -
| -
| |
| |
- Legislation and procedures applied to pharmaceutical industry, part a : legislation - Catherine Druez
| 10
| 5
| -
| |
| |
- Legislation and procedures applied to pharmaceutical industry, part b : patents and protection - Patrick Di Stefano
| 5
| -
| -
| |
| |
- Environnment macro-économique et pharmaco-économie - Alain De Wever
| 10
| -
| -
| |
| |
- CTD File (Common Technical Document) - Jean‑Antoine De Muylder
| 15
| -
| -
| |
| |
- Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files - Sonia Beken
| 15
| -
| -
| |
| |
- Regulations of preclinical and clinical studies, part b : clinical studies - A Lenaers
| 5
| -
| -
| |
| |
- Regulations of preclinical and clinical studies, part c : pediatric studies - Daniel Brasseur
| 2,5
| -
| -
| |
| |
- Specific regulatory issues, part a : medicine and herbal dietary supplement - Monique Tits
| 5
| -
| -
| |
| |
- Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique - Francis Verbist
| 5
| -
| -
| |
|
PHIN2032-1
|
Visits and seminars organised in the pharmaceutical industry - Collégialité - [77,5h Vis.]
| -
| -
| [+]
| 3
|
|
MTFE2000-1
|
Final work - Collégialité
| -
| -
| -
| 15
|
